Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-HBV specific beta-L-2'-deoxynucleosides.

M L Bryant1, E G Bridges, L Placidi

  • 1Novirio Pharmaceuticals, Inc., 125 Cambridge Park Dr., Cambridge, Massachussetts 02476, USA. bryant.martin@novirio.com

Nucleosides, Nucleotides & Nucleic Acids
|September 21, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral autonomic dysregulation in response to standing: a new form associated with cardiovascular disease, mobility reduction, and cognitive alterations.

European heart journal·2026
Same author

The effect of surgical complications on trauma and orthopaedic trainees.

Annals of the Royal College of Surgeons of England·2026
Same author

Bisphosphonate drug holidays in osteoporosis according to fracture risk profile.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2024
Same author

Quality analysis and categorisation of public space.

Heliyon·2023
Same author

Impact of socioeconomic inequalities on dental caries in deprived children: a multilevel analysis.

Community dental health·2022
Same author

Experimental study of the potential for thermal energy recovery with thermoelectric devices in low displacement diesel engines.

Heliyon·2021
Same journal

Can the combination of 5-fluorouracil and gemcitabine increase the treatment efficacy of pancreatic and colon cancer?

Nucleosides, nucleotides & nucleic acids·2026
Same journal

"Aptamer-guided therapeutics and diagnostics for metabolic syndrome: Design, delivery, and translation of aptamer-based systems".

Nucleosides, nucleotides & nucleic acids·2026
Same journal

The impact of vitamin B12 deficiency on urinary profile of <i>de novo</i> purine synthesis intermediates: consequences of the methylfolate trap.

Nucleosides, nucleotides & nucleic acids·2026
Same journal

Evaluation of MTH1 and DCTPP1 inhibitors in fluorocyclopentenylcytosine (RX-3117) resistant lung cancer cells and potential cross resistance patterns.

Nucleosides, nucleotides & nucleic acids·2026
Same journal

Circular RNAs: promising biomarkers for diagnosis, prognosis and therapy in oral squamous cell carcinoma.

Nucleosides, nucleotides & nucleic acids·2026
Same journal

Gene therapy, RNA-based drugs, and CRISPR in neuroprotection.

Nucleosides, nucleotides & nucleic acids·2026
See all related articles

New L-nucleosides show promise for treating chronic hepatitis B virus (HBV) infection. These compounds specifically inhibit HBV replication without affecting human DNA polymerases or mitochondria.

Area of Science:

  • Virology
  • Medicinal Chemistry
  • Hepatology

Background:

  • Chronic hepatitis B virus (HBV) infection remains a significant global health concern.
  • Current therapies have limitations, necessitating the development of novel antiviral agents.
  • Unnatural nucleosides represent a promising class of antiviral compounds.

Purpose of the Study:

  • To discover and characterize novel L-nucleoside analogs with specific anti-HBV activity.
  • To investigate the structure-activity relationship of these compounds.
  • To evaluate their safety and efficacy in preclinical models.

Main Methods:

  • Synthesis of a series of simple unnatural L-nucleosides.
  • In vitro antiviral activity assays against HBV.

Related Experiment Videos

  • Assessment of selectivity against hepadnaviruses.
  • Evaluation of effects on human DNA polymerases and mitochondrial function.
  • In vivo studies in a woodchuck model of chronic HBV infection.

    • Main Results:

    • A unique series of L-nucleosides specifically inhibit HBV replication.
    • A 3'-hydroxyl group on the beta-L-2'-deoxyribose sugar is crucial for hepadnavirus specificity.
    • Modifications in the base or replacement of the 3'-OH group alter antiviral spectrum and potency.
    • Compounds demonstrated no significant impact on human DNA polymerases or mitochondrial function.
    • Significant reduction (up to 8 logs) in plasma viremia observed in a woodchuck HBV model.

    Conclusions:

    • Novel L-nucleosides with a specific 3'-OH moiety are potent and selective inhibitors of HBV replication.
    • These compounds exhibit a favorable safety profile, sparing human DNA polymerases and mitochondria.
    • Preclinical data suggest these investigational drugs hold potential as new therapeutic options for chronic HBV infection.